Ultime notizie per Pelthos Therapeutics (AMEX:PTHS) Azioni

Pelthos Therapeutics Inc is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Pelthos Therapeutics Inc

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Apimeds Pharmaceuticals US, Inc. Common Stock

Apimeds Pharmaceuticals

BioVie

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

Carisma Therapeutics, Inc. - Common Stock

CARISMA Therapeutics

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics

Curis

Evaxion

FibroGen

HOOKIPA Pharma

Longeveron

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma

Lisata Therapeutics

Mustang Bio

MEI Pharma

Marker Therapeutics

NuCana

Plus Therapeutics

Pelthos Therapeutics

Q32 Bio

Rallybio

SAB Biotherapeutics

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Comments

Pelthos Therapeutics

Notizie

Ultime notizie per Pelthos Therapeutics (AMEX:PTHS) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO